Avricore Health Inc. (AVCRF)

OTCMKTS · Delayed Price · Currency is USD
0.0594
+0.0117 (24.53%)
Feb 12, 2026, 9:42 AM EST
Market Cap5.59M +11.3%
Revenue (ttm)1.38M -59.3%
Net Income-1.17M
EPS-0.01
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume116,105
Open0.0594
Previous Close0.0477
Day's Range0.0594 - 0.0594
52-Week Range0.0129 - 0.0787
Beta0.19
RSI51.46
Earnings DateApr 28, 2026

About Avricore Health

Avricore Health Inc. engages in the health data and point-of-care technologies business. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada. [Read more]

Sector Healthcare
Founded 1996
Employees 26
Stock Exchange OTCMKTS
Ticker Symbol AVCRF
Full Company Profile

Financial Performance

In 2024, Avricore Health's revenue was 4.79 million, an increase of 37.32% compared to the previous year's 3.49 million. Losses were -668,977, -4.60% less than in 2023.

Financial numbers in CAD Financial Statements

News

HealthTab™ to Expand Across North East London

VANCOUVER, British Columbia, Jan. 14, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) today announced the planned expansion of its HealthTab™ platform across N...

4 weeks ago - GlobeNewsWire

Avricore Grants Options

VANCOUVER, British Columbia, June 14, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) today announces that the Company's board of directors has approved the gr...

8 months ago - GlobeNewsWire

Avricore Appoints Rodger Seccombe as CEO

VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) is pleased to report the appointment of Rodger Seccombe as CEO of the Com...

9 months ago - GlobeNewsWire

AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report

VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) reports on its result for the first quarter of 2025 and its progress towa...

9 months ago - GlobeNewsWire

AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track

VANCOUVER, British Columbia, May 01, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) reports on its year end 2024 and In the year ended December 31, 2024 reven...

10 months ago - GlobeNewsWire

HealthTab™ and Patients Know Best® Bring Pharmacy-Based Blood Test Results to Millions in UK

VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Avricore Health Inc.  (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) today announced its successful integration of HealthT...

1 year ago - GlobeNewsWire

Avricore Health Corporate Update: Effective Plan, Resources Result in Success

VANCOUVER, British Columbia, Nov. 29, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) reports on its third quarter results for 2024 where the Company continues...

1 year ago - GlobeNewsWire

Avricore Health Refocuses Strategy to Unlock Growth Potential

VANCOUVER, British Columbia, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSX-V: AVCR) ("Avricore" or the "Company"), a leader in pharmacy-based point-of-care testing solutions, today annou...

1 year ago - GlobeNewsWire

Avricore Health Recognized in Deloitte's 2024 Technology Fast 50™ Companies to Watch

VANCOUVER, British Columbia, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSX-V: AVCR), a leader in pharmacy-based health technology solutions, proudly announces its placement in Deloitte C...

1 year ago - GlobeNewsWire

Avricore Grants Options

VANCOUVER, British Columbia, Aug. 30, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) today announces that the Company's board of directors has approved the gr...

1 year ago - GlobeNewsWire

Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability

VANCOUVER, British Columbia, Aug. 29, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) reports on its mid-year results for 2024 demonstrating the Company's cont...

1 year ago - GlobeNewsWire

Avricore Health Corporate Update and Audited Results for 2023

VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to announce its audited results for 2023.

1 year ago - GlobeNewsWire

HealthTab™ Signs Agreement for More Rexall® Pharmacy Locations

VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- Avricore Health Inc.  (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce further expansion of HealthTa...

2 years ago - GlobeNewsWire

Avricore Health Corporate Update – Company Demonstrates Strong Growth

VANCOUVER, British Columbia, Nov. 30, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) reports on its third quarter results which demonstrate significant growth in ...

2 years ago - GlobeNewsWire

HealthTab™ Supports Patient Testing in the First Rexall® Pharmacy Walk-In Clinic

VANCOUVER, British Columbia, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc.  (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is expanding its innovative point-of-care chronic an...

2 years ago - GlobeNewsWire

Avricore Health Corporate Update – Mid-Year Review Demonstrates Company on Right Track

VANCOUVER, British Columbia, Aug. 30, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) continues to achieve significant growth, new partnerships and developing new ...

2 years ago - GlobeNewsWire

HealthTab™ Signs Reseller Agreement With Abbott to Support UK Expansion

VANCOUVER, British Columbia, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc.  (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a reseller agre...

2 years ago - GlobeNewsWire

Avricore Health Hosts 2023 Annual General Meeting and Welcomes New Board Members

VANCOUVER, British Columbia, June 21, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) held its annual general meeting to elect directors, appoint its auditor and a...

2 years ago - GlobeNewsWire

Avricore Health Corporate Updates on Audited Results for 2022

The Company will host an investor update call on May 3rd with CEO Hector Bremner to share the Company's outlook and take questions The Company will host an investor update call on May 3rd with CEO Hec...

3 years ago - GlobeNewsWire

Avricore Health's HealthTab™ Passes 530 Locations, Adds Virus Detection

VANCOUVER, British Columbia, March 23, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) continues to grow the HealthTab™ network of pharmacy locations, reaching 532...

3 years ago - GlobeNewsWire

Avricore Health Makes the Grade on 2023 TSX Venture 50

VANCOUVER, British Columbia, Feb. 21, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) has been honoured by being named as one of the 2023 Venture 50, the TSX Ventu...

3 years ago - GlobeNewsWire

Avricore Health Reports Third-Quarter 2022 Results

VANCOUVER, British Columbia, Nov. 29, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) today released its Q3 results which demonstrate significant revenue growth, i...

3 years ago - GlobeNewsWire

Avricore Health Announces CEO Update Call on Sept. 22, 2022

VANCOUVER, British Columbia, Sept. 20, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is excited to offer a live discussion on the Company's current activities an...

3 years ago - GlobeNewsWire

Avricore Health Supports the Globe and Mail's Health Innovation Event

VANCOUVER, British Columbia , Sept. 19, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) was honoured to join the Globe and Mail's recent Health Care Innovation eve...

3 years ago - GlobeNewsWire

Avricore Health Reports Second-Quarter 2022 Results

VANCOUVER, British Columbia, Aug. 29, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to provide this corporate update on the Company's Q2 results.

3 years ago - GlobeNewsWire